Genesis Energy
GEL
14.32
+0.04
+0.28%
Genesis Energy
US · GEL
#2897 by market cap
Listed 1970
14.32
+0.04
+0.28%
Live - 5344 symbols - heartbeat 139s ago
· 2026-10-08 07:37
Pre-market
14.32
0.00%
After-hours
14.32
0.00%
- Market cap
- 1.75B
- P/E (TTM)i
- 68.19
- P/Bi
- -149.17
- EPSi
- -4.19
- Div yieldi
- 4.82%
- 52W posi
- 17%
Reader sentiment
Are you bullish or bearish on GEL?
Anonymous reader poll. Unscientific, not investment advice.
Recent news
-
Rating change
Wells Fargo Initiates Genesis Energy(GEL.US) With Buy Rating, Announces Target Price $18Market Newswire · 2026/8/14
-
Rating change
Mizuho Securities Initiates Sol-Gel Technologies(SLGL.US) With Buy Rating, Announces Target Price $285Market Newswire · 2026/6/24
-
Beiteli (301697.SZ): Thermal conductive gel samples have been delivered to leading optical module clients, but sales have not yet commenced.Gelonghui Finance · 2026/9/7
-
Company notice
Sol-Gel Technologies | 4: Statement of changes in beneficial ownership of securities-10% Owner Opaleye Management Inc.SEC · 2026/9/4
-
Rating change
LifeSci Capital Maintains Sol-Gel Technologies(SLGL.US) With Buy Rating, Maintains Target Price $184Market Newswire · 2026/8/18
-
Beiteli (301697.SZ): Its thermal conductive gel products are applicable to the data center sector and are currently in the sample testing phase.Gelonghui Finance · 2026/9/7
-
Rating change
LifeSci Capital Initiates Sol-Gel Technologies(SLGL.US) With Buy Rating, Announces Target Price $184Market Newswire · 2026/5/15
-
Company notice
C'BON COSMETICS: Both the Sea and the bright impression. With W ingredient* and W concentration*, the targeted, rich gel serum "Seeboon AC W Shot Serum" has arrived.JPX · 2026/9/24
-
Rating change
H.C. Wainwright Maintains Sol-Gel Technologies(SLGL.US) With Buy Rating, Maintains Target Price $110Market Newswire · 2026/7/20
-
Rating change
Wells Fargo Maintains Genesis Energy(GEL.US) With Buy Rating, Cuts Target Price to $18Market Newswire · 2026/5/13
-
Mizuho Securities Maintains Sol-Gel Technologies(SLGL.US) With Buy Rating, Maintains Target Price $285Market Newswire · 2026/8/21
-
Palvella Therapeutics Receives Third Year Of Grant Funding From FDA Office Of Orphan Products Development For Phase 3 SELVA Trial And Ongoing Open-Label Extension Study Of QTORIN 3.9% Rapamycin Anhydrous Gel For Treatment Of Microcystic Lymphatic...Benzinga · 2026/9/28
-
Company notice
Sol-Gel Technologies | 4: Statement of changes in beneficial ownership of securities-10% Owner Opaleye Management Inc.SEC · 2026/9/10
-
Rating change
TD Cowen Initiates Sol-Gel Technologies(SLGL.US) With Buy RatingMarket Newswire · 2026/5/29
-
LifeSci Capital Maintains Sol-Gel Technologies(SLGL.US) With Buy Rating, Maintains Target Price $195Market Newswire · 2026/8/23
-
Rating change
RBC Capital Maintains Genesis Energy(GEL.US) With Buy Rating, Cuts Target Price to $18Market Newswire · 2026/7/22
-
Company notice
Kowa: Regarding the sale of walking aids equipped with "αGEL" material grips, under a partnership with Taika Co., Ltd.JPX · 2026/9/14
-
Rating change
LifeSci Capital Maintains Sol-Gel Technologies(SLGL.US) With Buy Rating, Raises Target Price to $195Market Newswire · 2026/8/20
-
Rating change
HC Wainwright & Co. Reiterates Buy on Sol-Gel Technologies, Maintains $110 Price TargetBenzinga · 2026/7/20
-
Company notice
Sol-Gel Technologies | 4: Statement of changes in beneficial ownership of securities-10% Owner Opaleye Management Inc.SEC · 2026/9/15
Headlines are aggregated automatically and are not independently verified or edited by our team.
Quote time 2026-10-08 07:37:42 · For reference only, not investment advice and not tailored to your situation.